531661 Sigma-AldrichSMYD2 Inhibitor, AZ505 - CAS 1035227-43-0 - Calbiochem
AZ505 is a cell-permeable, potent, reversible inhibitor of SMYD2 (IC₅₀ = 120 nM, Ki = 300 nM) that binds to the peptide-binding groove of the enzyme.
More>> AZ505 is a cell-permeable, potent, reversible inhibitor of SMYD2 (IC₅₀ = 120 nM, Ki = 300 nM) that binds to the peptide-binding groove of the enzyme. Less<<Synonyms: N-Cyclohexyl-3-(3,4-dichlorophenethylamino)-N-(2-(2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethylamino)ethyl)propanamide, HMTase Inhibitor XV
Recommended Products
Overview
| Replacement Information | 
|---|
Key Spec Table
| CAS # | Empirical Formula | 
|---|---|
| 1035227-43-0 | C₂₉H₃₈Cl₂N₄O₄ | 
| References | |
|---|---|
| References | Ferguson, A.D., et al. 2011. Structure 19, 1262. | 
| Product Information | |
|---|---|
| CAS number | 1035227-43-0 | 
| Form | Off-white solid | 
| Formulation | Supplied as a di-trifluoroacetate salt. | 
| Hill Formula | C₂₉H₃₈Cl₂N₄O₄ | 
| Chemical formula | C₂₉H₃₈Cl₂N₄O₄ | 
| Reversible | Y | 
| Quality Level | MQ100 | 
| Applications | 
|---|
| Biological Information | |
|---|---|
| Primary Target | SMYD2 | 
| Purity | ≥95% by HPLC | 
| Physicochemical Information | |
|---|---|
| Cell permeable | Y | 
| Dimensions | 
|---|
| Materials Information | 
|---|
| Toxicological Information | 
|---|
| Safety Information according to GHS | 
|---|
| Safety Information | 
|---|
| Product Usage Statements | 
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas | 
| Transport Information | 
|---|
| Supplemental Information | 
|---|
| Specifications | 
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN | 
| 531661 | 0 | 
Documentation
SMYD2 Inhibitor, AZ505 - CAS 1035227-43-0 - Calbiochem SDS
| Title | 
|---|
References
| Reference overview | 
|---|
| Ferguson, A.D., et al. 2011. Structure 19, 1262. | 
Technical Info
| Title | 
|---|
| Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System | 
| White Paper: Further considerations of antibody validation and usage. | 

 


 
  

 
 
 
 
 
 
 
